COMMUNIQUÉS West-GlobeNewswire

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/06/2026
BOSTON, June 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that, effective June 1, 2026, the Compensation Committee of Tango Therapeutics' Board of Directors granted a non- [...]
Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development
05/06/2026
Company to share additional CLYM116 clinical data and plans for further development at R&D Spotlight in late summer Initiation of CLYM116 dosing in IgAN patients in Mabworks Phase 2 study expected in Q3 2026 [...]
Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
05/06/2026
WATERTOWN, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/06/2026
BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/06/2026
SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar
05/06/2026
Yale and Johns Hopkins Researchers to Present Early Findings on MEAI Next Week in Live Webinar Register now for free and join on June 10, 2026 Vancouver, Canada, June 05, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc [...]
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
05/06/2026
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels PARMA [...]
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
05/06/2026
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, attended the 2026 Tencent Cloud AI Industry [...]
New Health Economic Evidence Shows Health & Cost Benefits When Starting Dialysis at Home
05/06/2026
New UK economic analyses show improved patient outcomes and health system savings – including nearly £200 million in projected UK NHS savings over 5 years – through increased uptake of home-based peritoneal dialysis [...]
Iron Age Nutrition Announces Launch of “Sour Apple Crush” Flavor in Total Hydrate Electrolyte Line
05/06/2026
FORT LAUDERDALE, FL, June 04, 2026 (GLOBE NEWSWIRE) -- Iron Age Nutrition announced the introduction of “Sour Apple Crush,” a new flavor within its Total Hydrate electrolyte line. The addition expands the company’s [...]
Research Peptides: Koi Research Labs Expands Distribution Across USA & Canada
05/06/2026
NEW YORK, NY, June 05, 2026 (GLOBE NEWSWIRE) -- Koi Research Labs today announced the expansion of its research-grade peptide distribution across the United States and Canada, giving qualified researchers in both [...]
Addex Convenes Annual General Meeting 2026
05/06/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 5, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR
05/06/2026
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that study results [...]
Native Life Appoints FIFA Brand Designer Jody Ure to Lead Creative Strategy and Support National Expansion
05/06/2026
Miami, Florida, June 04, 2026 (GLOBE NEWSWIRE) -- Native Life, an emerging life and health insurance company operating across all 50 states, announced the appointment of globally recognized FIFA brand designer Jody Ure [...]
Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme Lancement du processus de transition vers un Chief Executive Officer basé aux États-Unis Cette [...]
Nyxoah Enters New Chapter of Long Term Value Creation
04/06/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Enters New Chapter of Long Term Value Creation Commencement of process to transition to a U.S.-based CEO Transition to support further acceleration of commercial Genio [...]
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires Mont-Saint-Guibert, Belgique – 4 juin 2026, 22h02 CET / 16h02 ET – Nyxoah SA (Euronext Brussels/Nasdaq : [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on June 1, 2026, the Company [...]
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
04/06/2026
BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it [...]

Pages